Physical ActivityBOUGE CANCERNCT03674515
Study of Program Interest "Bouge" to Improve the Daily Physical Activity in Processings Treatment of Non-metastatic Breast Cancer
A study testing Smartphone equipped with application "bouge" = Coach group in people with Physical Activity and Breast Cancer, run by University Hospital, Brest at 2 sites in France.
Trial summary
Evaluate the "Bouge" digital program (smartphone application) to increase the daily physical activity of breast cancer patients Read more about this study
- Who is it for?
- Ages 18 to 70 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Physical Activity, Breast Cancer, Mobile Health Apps
- What is being tested?
- Smartphone equipped with application "bouge" = Coach group
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 23 participants
- Where
- 2 sitesFrance
- Study dates
- 14 Dec 2017to 12 Nov 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- non-metastatic breast cancer start of treatment with TAXOL compatible smartphone
Who cannot join
- age metastatic breast cancer
Trial locations and contacts
2 sites in 1 country.
France2 sites
CHRU de Brest
Brest, Brest, 29609
CHU de Morlaix
Morlaix, Morlaix, 29200
About this study
Official title: Study of Program Interest "Bouge" to Improve the Daily Physical Activity and Tolerance in Processings Treatment of Non-metastatic Breast Cancer at the Beginning Weekly Taxol Adjuvant Chemotherapy (Www.Bouge-coaching.Com)
Evaluate the "Bouge" digital program (smartphone application) to increase the daily physical activity of breast cancer patients
Read the detailed description
Controlled, randomized, open, prospective, multicentric study, 214 volunteer patients aged between 18 and 70, with breast cancer, at the start of TAXOL treatment, possessing a smartphone, will be recruited and randomized into two groups:
107 in the control group (smartphone application "placebo" = number of steps) 107 will be equipped with the application "Bouge" = coached group
For three months, the patients do their daily physical activity. The "coached" group, through the smartphone application "Bouge", receives computer coaching to increase their physical activity (no direct medical intervention, only notifications and computer pusch).
The control group is not coached by the application (simple display of the number of step)
- Conditions
- Physical Activity, Breast Cancer, Mobile Health Apps
- Being tested
- Smartphone application "placebo", Smartphone equipped with application "bouge" = Coach group
- Medical subject headings
- Motor Activity, Breast Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Smartphone application "placebo"Device
Strategy based on smartphone application "placebo"
Smartphone equipped with application "bouge" = Coach groupDevice
Strategy based on smartphone application "bouge"
| Study group | Role | What they receive |
|---|---|---|
| placebo | Placebo comparator | Smartphone application "placebo" Receives: Device: Smartphone application "placebo" |
| "Bouge" | Active comparator | Smartphone equipped with the application "Bouge" Receives: Device: Smartphone equipped with application "bouge" = Coach group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Increased daily physical activity (number of steps) using the smartphone application "BOUGE"
The objective is an increase of 3000 steps daily between J 1 and J 90 (an increase of 15 000 steps between S1 and S 12)
Measured: 12 weeks
Secondary outcomes (4)
Well-being,
Scale EQ-5D-5L,
Measured: 12 weeks
Well-being,
Scale EORTC QLQ-C30,
Measured: 12 weeks
Fatigue
Scale WHO
Measured: 12 weeks
Sleep
Scale SPIEGEL
Measured: 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Sep 2018
- Study start14 Dec 2017
- Primary completion12 Nov 2018
- Study completion12 Nov 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Physical ActivityStudies of the same condition, open and under way.
- More trials run by University Hospital, BrestThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 23 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Brest
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03674515
- Sponsor's protocol ID
- BOUGE CANCER (29BRC17.0038)
- Acronym
- BOUGE CANCER
- Status last verified
- Jun 2026
- First submitted
- 19 Feb 2018
- Last updated
- 8 Jun 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Study of Program Interest "Bouge" to Improve the Daily Physical Activity and Tolerance in Processings Treatment of Non-metastatic Breast Cancer at the Beginning Weekly Taxol Adjuvant Chemotherapy (Www.Bouge-coaching.Com)
- ClinicalTrials.gov ID
- NCT03674515
- Acronym / sponsor ID
- BOUGE CANCER / BOUGE CANCER (29BRC17.0038)
- Conditions
- Physical Activity, Breast Cancer, Mobile Health Apps
- Study type
- Interventional
- Recruitment status
- Terminated
- Enrolment
- 23 participants (actual)
- Lead sponsor
- University Hospital, BrestUniversity, hospital or other
- Study start
- 14 Dec 2017 (actual)
- Primary completion
- 12 Nov 2018 (actual)
- Study completion
- 12 Nov 2018 (actual)
- First posted
- 17 Sep 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Evaluate the "Bouge" digital program (smartphone application) to increase the daily physical activity of breast cancer patients
Detailed description
Controlled, randomized, open, prospective, multicentric study, 214 volunteer patients aged between 18 and 70, with breast cancer, at the start of TAXOL treatment, possessing a smartphone, will be recruited and randomized into two groups:
107 in the control group (smartphone application "placebo" = number of steps) 107 will be equipped with the application "Bouge" = coached group
For three months, the patients do their daily physical activity. The "coached" group, through the smartphone application "Bouge", receives computer coaching to increase their physical activity (no direct medical intervention, only notifications and computer pusch).
The control group is not coached by the application (simple display of the number of step)
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| placebo | Placebo comparator | Device: Smartphone application "placebo"Smartphone application "placebo" |
| "Bouge" | Active comparator | Device: Smartphone equipped with application "bouge" = Coach groupSmartphone equipped with the application "Bouge" |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- non-metastatic breast cancer start of treatment with TAXOL compatible smartphone
Key exclusion criteria (1 listed)
- age metastatic breast cancer
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Smartphone application "placebo"Strategy based on smartphone application "placebo" | Device | placebo |
| Smartphone equipped with application "bouge" = Coach groupStrategy based on smartphone application "bouge" | Device | "Bouge" |
Primary outcome
Increased daily physical activity (number of steps) using the smartphone application "BOUGE"
Time frame: 12 weeks
The objective is an increase of 3000 steps daily between J 1 and J 90 (an increase of 15 000 steps between S1 and S 12)
4 secondary outcomes
Well-being,
Time frame: 12 weeks
Well-being,
Time frame: 12 weeks
Fatigue
Time frame: 12 weeks
Sleep
Time frame: 12 weeks
Results and safety
The study was stopped early. Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jun 2026.
Related trials for Physical Activity
Recruiting
THE EFFECTS OF GAME-BASED EXERCISE PROGRAMS
Physical Activity, Body Image
Not yet recruiting
Feasibility of a Robot-Guided Active Play Intervention for Children With Cerebral Palsy
Cerebral Palsy
Enrolling by invitation
Online Exercise Program for Transplant Patients: A Pilot Study
Kidney Transplantation, Physical Function
Recruiting
Effect of a Brief Daily Digital Meditation on Well-Being in US Young Adults (BEGIN II)
Mental Health and General Well-being
RecruitingPhase 4
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)
Heart Failure With Reduced Ejection Fraction, Iron Deficiency
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Smartphone equipped with application "bouge" = Coach group in people with Physical Activity and Breast Cancer, run by University Hospital, Brest at 2 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 8 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early. Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Increased daily physical activity (number of steps) using the smartphone application "BOUGE" (time frame: 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2026.